BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
BioPharm Executive - Bench To Clinic
Bay Area's InterMune, Inc. (ITMN) Gains As Boehringer Ingelheim Corporation's Rival Drug Shows Mixed Results 3/24/2014  More...
Endocyte, Inc. (ECYT) Doubles After Drug Shown To Slow Lung Cancer In Phase 2b Study 3/24/2014  More...
Geron Corporation (GERN) Says FDA Halts Patient Enrollment In Another Cancer Trial 3/21/2014  More...
Amgen (AMGN) Drug Meets Phase 3 Goals For Those With High Genetic Cholesterol 3/18/2014  More...
Intercept Pharmaceuticals (ICPT) Drug Scores Pivotal Phase 3 Win Against Rare Liver Disease 3/18/2014  More...
Raptor Pharmaceutical Inc. (RPTP) Surges As Huntington's Drug Meets Study Endpoints 2/21/2014  More...
PRANA Biotechnology (PRAN) Soars As Brain Disorder Drug Succeeds In Phase 2 Trial; Stock Up +39.31% At Market Close (February 18, 2014) 2/19/2014  More...
Shire plc Scraps Vyvanse® For Depression After Failed Phase 3 Trials 2/7/2014  More...
Furiex Pharmaceuticals, Inc. (FURX) Shares Double As Irritable Bowel Drug Succeeds In Phase 3 Trials 2/5/2014  More...
AbbVie (ABBV)'s Interferon-Free Hepatitis C Cocktail Excels In Ph3 Study 2/3/2014  More...
ArQule, Inc. (ARQL) Soars As FDA Panel Favors Continuation Of Liver Cancer Drug Study, Stock Up +6.78% At Market Close (January 17, 2014) 1/17/2014  More...
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT) Surges Following Results Of Phase 2b Eteplirsen Therapy 1/17/2014  More...
As Big Biotech Talks Cancer Vaccines, Bay Area's Aduro Biotech Nails Mid-Stage Pancreatic Cancer Study 1/16/2014  More...
Intercept Pharmaceuticals (ICPT) Falls As CEO Says It May Need Help Big Pharma's Help 1/14/2014  More...
Neurocrine Biosciences, Inc. (NBIX) Rockets On Positive Phase 2 Movement Disorder Drug Data; Stock Up +75.56% At Market Close (January 7, 2014) 1/8/2014  More...
Cubist Pharmaceuticals, Inc. (CBST) Takes Off As Antibiotic Succeeds In Late-Stage Trial 12/18/2013  More...
Novartis AG (NVS) Bone Marrow Cancer Drug Wows In Late-Stage Study 12/9/2013  More...
Johnson & Johnson (JNJ), Pharmacyclics, Inc. (PCYC)'s Closely Watched Leukemia Drug Effective In Long Term Study 12/9/2013  More...
Geron Corporation (GERN) Soars After Study Shows Bone Marrow Drug's Benefit 12/9/2013  More...
Eli Lilly and Company (LLY)'s Depression Drug, Edivoxetine, Fails Late-Stage Trials 12/6/2013  More...
Cubist Pharmaceuticals, Inc. (CBST)'s Urinary Tract Infection Drug Succeeds In Phase 3 Study 11/27/2013  More...
Amgen (AMGN)'s Experimental Heart Drug Appears To Be Safe, Cuts LDL By Half At 1 Year Study 11/20/2013  More...
AbbVie (ABBV), Enanta Pharmaceuticals, Inc.'s Hepatitis C Treatment Helps 96 Percent Of Patients In Phase 3 Studies 11/19/2013  More...
GlaxoSmithKline (GSK) Heart Drug Misses Goal In Major Study 11/13/2013  More...
Geron Corporation (GERN) Skyrockets as Cancer Drug is Highly Effective in Trial, Shares Up +44.72% @ Market Close (November 7, 2013) 11/8/2013  More...
Astellas Pharma Inc. (ALPMY), Medivation, Inc. (MDVN) Prostate Cancer Drug Meets Phase 3 Trial Goals 10/22/2013  More...
Ariad Pharmaceuticals, Inc. (ARIA) Discontinues Phase 3 Study of Cancer Drug Iclusig; Shares Decimated, Falls -40.67% at Market Close (October 18, 2013) 10/22/2013  More...
Vertex Pharmaceuticals (MA) (VRTX)'s VX-509 Showed Positive Results for Rheumatoid Arthritis in Phase 2b Study 10/21/2013  More...
Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN) Drug Slashes Cholesterol in Phase 3 Trial 10/21/2013  More...
Gilead Sciences, Inc. (GILD)'s Idelalisib Works Against Leukemia, Phase 3 Trial Stopped Early; Stock Up +6.42% at Market Close (October 10, 2013) 10/14/2013  More...
GlaxoSmithKline (GSK), ProSensa Holding N.V. (RNA)'s Muscular Dystrophy Drug Fails in Phase 3 Trial; ProSensa Stock Plunges -70.25% at Market Close on September 20, 2013 9/23/2013  More...
Isis Pharmaceuticals, Inc. (ISIS) Rises on Positive Phase 1 Spinal Muscular Data 9/20/2013  More...
Kythera Biopharmaceuticals (KYTH)' Drug Successfully Reduces Double Chin in Studies 9/19/2013  More...
Bristol-Myers Squibb Company (BMY) Prostate Cancer Treatment Falls Short in Phase 3 Trial 9/13/2013  More...
Celgene International Sárl (CELG) Reports POMALYST Met Prrimary Endpoint in Phase 3 Trial 9/5/2013  More...
GlaxoSmithKline (GSK)'s Crohn's Disease Drug Fails Phase 3 Trial, ChemoCentryx, Inc. (CCXI) Stock Falls -32.12% on Friday at Market Close (August 23, 2013) 8/26/2013  More...
Incyte Corporation (INCY) Surges on Positive Phase 2 Pancreatic Cancer Data; Stock Rockets +33.48% Wednesday, August 21, 2013 at Market Close 8/23/2013  More...
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT) Up, Then Down, on DMD Competitor's Trial Results 8/21/2013  More...
MannKind Corporation (MNKD) Rockets on Positive Drug Data 8/16/2013  More...
Vertex Pharmaceuticals (MA) (VRTX) Shares Rocket as CF Drug Impresses in Phase 3 Study 8/1/2013  More...
Vertex Pharmaceuticals (MA) (VRTX) Tanks as FDA Puts Hold on Hep C Trial 7/30/2013  More...
Isis Pharmaceuticals, Inc. (ISIS) Drug Reduces Blood Fat by 64 Pct in Phase 2 Study 7/24/2013  More...
Array BioPharma, Inc. (ARRY)'s ARRY-502 Meets Goals in Asthma Study 7/23/2013  More...
Celgene Corporation (CELG)'s Revlimid Improves Survival in Blood Cancer Patients 7/12/2013  More...
Alnylam Pharmaceuticals (ALNY) Reports Positive Top-Line Results for ALN-TTRsc 7/11/2013  More...
Janssen Research & Development's Ibrutinib Monotherapy Shows Efficacy in Patients With MCL or DLBCL 6/17/2013  More...
Amgen (AMGN) Shows Off Phase 3 Ovarian Cancer Data 6/14/2013  More...
Merck & Co., Inc. (MRK) Melanoma Drug Shrinks Tumors in 38 Percent of Patients: Study 6/4/2013  More...
Clovis Oncology (CLVS) Shares Almost Double on Cancer Drug Trial 6/4/2013  More...
Alkermes plc (ALKS) Unveils Full Mid-Stage Data on Depression Drug 5/31/2013  More...
Pfizer Inc. (PFE) Halts Study of Non-Hodgkin's Lymphoma Drug 5/29/2013  More...
Bristol-Myers Squibb Company (BMY) Drug Cocktail Stymies Melanoma Tumors 5/17/2013  More...
Experimental Gilead Sciences, Inc. (GILD) Drug Effective in Early-Stage Leukemia Trial 5/16/2013  More...
Infinity Pharmaceuticals Inc. (INFI) Announces Clinical Data to be Presented at American Society of Clinical Oncology and ICML 5/16/2013  More...
Amgen (AMGN) Late-Stage Trial of Colon Cancer Drug Meets Goal 5/10/2013  More...
Vertex Pharmaceuticals Incorporated (VRTX) Booms on Cystic Fibrosis Combo Drug Study 4/23/2013  More...
Alkermes plc (ALKS) Has Jumped to a New High on Study Results 4/17/2013  More...
FDA Asks ACADIA Pharmaceuticals, Inc. (ACAD) to Skip Late Stage Study and File NDA After Successful Results 4/11/2013  More...
GlaxoSmithKline (GSK) Muscular Dystrophy Drug Reaches Primary Objective in Study 4/10/2013  More...
Liver Toxicity Brings Melanoma Study on Bristol-Myers Squibb Company (BMY)/Roche (RHHBY) Drugs to a Halt 4/4/2013  More...
Amgen (AMGN)'s Melanoma Drug Shows Promise in Key Trial 3/20/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB)'s Injectable MS Drug Cut Relapse Rate by 36 Pct 3/20/2013  More...
Merck & Co., Inc. (MRK) Says a Crucial Vytorin Study Will Continue 3/13/2013  More...
Celgene Corporation (CELG)'s Apremilast Succeeds in Phase 3 Psoriasis Trial 3/5/2013  More...
FDA Halts Amgen (AMGN) Trial After Teen Death 3/4/2013  More...
AbbVie (ABBV) Suspends Five Clinical Trials of Leukemia Therapy After Patient Deaths 2/27/2013  More...
Genzyme Corporation (GENZ) Touts Positive Ph3 Drug Data 2/19/2013  More...
Gilead Sciences, Inc. (GILD) Sees Positive Results From Late-Stage Hepatitis C Treatment Study 2/19/2013  More...
Eli Lilly and Company (LLY) to Cease Tabalumab Phase 3 RA Program 2/8/2013  More...
Celsion Corporation (CLN)'s Plummets on Phase 3 Liver Cancer Failure 2/1/2013  More...
Pfizer Inc. (PFE) Reports Positive Results in Studies of Toviaz, Pristiq, Chantix 1/24/2013  More...
Celgene (CELG)'s Abraxane Keeps Pancreatic Pts Alive an Extra Two Months in Trial 1/24/2013  More...
Teva Pharmaceutical Industries Limited (TEVA)'s NUVIGIL® Fails Phase 3 Trial Again 1/23/2013  More...
Genentech (RHHBY) Takes Exelixis, Inc. (EXEL) Drug Into Phase III Melanoma Trial 1/22/2013  More...
The Medicines Company (MDCO) Jumps on Anti-Clotting Drug Study 1/9/2013  More...
Genentech (RHHBY) Preps for $100 Million Alzheimer's Trial 12/19/2012  More...
Oncolytics Biotech Inc. (ONC.TO) Soars on Positive Phase 3 Head and Neck Cancer Data 12/13/2012  More...
Celgene (CELG)'s Pomalidomide Helps in Myeloma After Others Fail 12/12/2012  More...
Stunning Data for Ambit Biosciences/Astellas Pharma Inc. (YPH.BE) AML Drug 12/11/2012  More...
Pfizer Inc. (PFE) New Breast Cancer Drug Heralded as Breakthrough 12/10/2012  More...
ViiV Healthcare Says Phase III Data From VIKING-3 Dolutegravir Study Encouraging 11/14/2012  More...
Johnson & Johnson (JNJ) Isn't Giving Up on Alzheimer Drug 11/13/2012  More...
Clavis Pharma ASA, Clovis Oncology (CLVS) Tank as Pancreatic Cancer Drug Fails Late-State Test 11/12/2012  More...
Amgen (AMGN) Drug Cuts Bad Cholesterol Up to 66 Pct in Patients - Trial 11/7/2012  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Hemophilia Drug Wows in Phase 3 Study 11/1/2012  More...
Bayer HealthCare (BAY)'s Lung Drug Shows Promise in Phase 3 Study 10/23/2012  More...
Pfizer Inc. (PFE) Kidney Cancer Drug Fails as Initial Treatment 10/18/2012  More...
Genentech (RHHBY)'s T-DM1 Stuns as Approval Creeps Up 10/10/2012  More...
Sanofi (France) (SAN.PA)'s Gaucher Pill Meets Goal in Phase 3 Trial 10/2/2012  More...
Pfizer Inc. (PFE)'s RA Drug Tofacitinib Tops Methotrexate in Phase III 9/18/2012  More...
Threshold Pharmaceuticals, Inc. (THLD) Plummets on Pancreatic Cancer Drug Study Survival Results 9/17/2012  More...
Sanofi (France) (SAN.PA) Dengue Vaccine Less Effective Than Hoped 9/12/2012  More...
Roche (RHHBY) Ramps Up Alzheimer's Drug Trial as Rivals Stumble 9/11/2012  More...
Merck & Co., Inc. (MRK) Insomnia Drug Shows Positive Phase III Results 9/11/2012  More...
Bristol-Myers Squibb Company (BMY) Ends Hepatitis C Development After Patient Death; Eats a $1.8 Billion Loss 8/27/2012  More...
Idenix Pharmaceuticals, Inc. (IDIX) Hepatitis C Drug Put on Partial Hold 8/17/2012  More...
Roche (RHHBY) Says Avastin Slows Brain Cancer Tumor Growth 8/10/2012  More...
Amgen (AMGN) Halts Pancreatic Cancer Trial After Drug Failure 8/10/2012  More...
Pfizer Inc. (PFE), Johnson & Johnson (JNJ) Scrap Alzheimer's Drug After Phase III Study Fails 8/8/2012  More...
Roche (RHHBY) Moves Secret Heart Drug to Phase III Trial 7/25/2012  More...
Biogen Idec, Inc. (Massachusetts) (BIIB), Bayer AG (BAY.F) Drugs Fail to Slow MS Progression 7/19/2012  More...
Baxter International, Inc. (BAX) Alzheimer's Drug Keeps Four Patients Stable for 3 Years 7/19/2012  More...
Alnylam Pharmaceuticals (ALNY) Gains on Treatment Data for Deadly Nerve Disease 7/18/2012  More...
Merck & Co., Inc. (MRK) Bone Drug Shows Benefits So Trial is Stopped 7/16/2012  More...
Pfizer Inc. (PFE): Xalkori Improves Lung Cancer Patients' Survival in Phase III Trial 6/19/2012  More...
Johnson & Johnson (JNJ) Prostate Cancer Drug So Effective Trial Stopped 6/5/2012  More...
Bristol-Myers Squibb Company (BMY) Immune Drug Shows Promise in Three Cancers, Success May Spur Industry Race 6/5/2012  More...
ImmunoGen, Inc. (IMGN) Announces Development of Trastuzumab Emtansine for Early Stage HER2-Positive Breast Cancer 6/4/2012  More...
GlaxoSmithKline (GSK) Melanoma Drugs Beat Chemo in Pivotal Trials 6/4/2012  More...
Eli Lilly and Company (LLY)'s Diabetes Drug Meets Mid-stage Trial Goal 5/23/2012  More...
GlaxoSmithKline (GSK)'s Melanoma Cocktail Slows Cancer in Study 5/21/2012  More...
Boehringer Ingelheim Corporation Reports Convincing Data for Lung Cancer Therapy 5/17/2012  More...
Pfizer Inc. (PFE)'s Torisel Fails Phase III Renal Cell Carcinoma Study in Showdown Against Bayer HealthCare (BAY)'s Nexavar 5/16/2012  More...
Vertex Pharmaceuticals (MA) (VRTX) Soars as Cystic Fibrosis Drug Regimen Improves Patients’ Breathing 5/8/2012  More...
Gilead Sciences, Inc. (GILD)-Bristol-Myers Squibb Company (BMY)'s Experimental Hepatitis C Drug Cured 88% Post-Therapy 4/20/2012  More...
GlaxoSmithKline (GSK) to File GLP-1 Diabetes Drug Albiglutide as Data Impresses 4/4/2012  More...
Keryx Biopharmaceuticals (KERX), AEterna Zentaris (AEZS) Colorectal Cancer Drug Fails Trial 4/3/2012  More...
New Genentech (RHHBY) Breast Cancer Drug Shows Late Stage Trial Success 4/2/2012  More...
AVI BioPharma, Inc. (AVII): Eteplirsen Study Shows No Significant Improvement in Walking 4/2/2012  More...
AstraZeneca PLC (AZN), Targacept, Inc. (TRGT) Give Up on Antidepressant Drug After All Four Phase 3 Studies Fail 3/21/2012  More...
Omeros Corporation (OMER)' Eye Drug OMS302 Meets Phase 3 Clinical Trial Goal 3/14/2012  More...
Anthera Pharmaceuticals, Inc. (ANTH) Tanks as it Halts Phase III VISTA-16 Heart Drug Trial 3/13/2012  More...
Johnson & Johnson (JNJ)'s Zytiga Scores Big Win, Hurts Dendreon Corporation (DNDN), Helps Medivation, Inc. (MDVN) 3/9/2012  More...
Gilead Sciences, Inc. (GILD)’s Four-in-One AIDS Pill is Effective in Study 3/8/2012  More...
Threshold Pharmaceuticals, Inc. (THLD) Soars on Positive Phase 2b Pancreatic Cancer Trial Results 2/22/2012  More...
Actelion Ltd. (ALIOF.PK) CEO Says 120 Patients Died in Lung Drug Study 2/21/2012  More...
Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Inflammatory Bowel Disease Drug Meets Phase 3 Targets 2/21/2012  More...
Gilead Sciences, Inc. (GILD) Drops as Patients Relapse on Hepatitis C Drug 2/21/2012  More...
Medivation, Inc. (MDVN) Soars as Prostate Cancer Drug is Well-tolerated in Phase 3 Trial 2/3/2012  More...
Pfizer Inc. (PFE) Ditches $725 Million Medivation, Inc. (MDVN) Pact as Phase 3 Alzheimer Trial Disappoints 1/20/2012  More...
Bristol-Myers Squibb Company (BMY) Hepatitis C Pills Clear Virus Without Injections 1/20/2012  More...
Bayer HealthCare (BAY)'s Colorectal Cancer Drug Regorafenib Shows Promise, Improves Overall Survival Rate by 29 Percent 1/18/2012  More...
Roche (RHHBY)'s Avastin Disappoints Against Ovarian Cancer 1/3/2012  More...
Study Challenges Bristol-Myers Squibb Company (BMY) on Bristol-Myers Squibb Company (BMY) and Sanofi (France) (SAN.PA)'s Plavix 12/29/2011  More...
Genentech (RHHBY)'s Two-Drug Strategy Raises the Bar in Breast Cancer, Positive Phase III Results Reported 12/9/2011  More...
Latest Data on Novartis AG (NVS) Afinitor Confirms Efficacy 12/9/2011  More...
GlaxoSmithKline (GSK) Drug Fails to Hit Goal in Breast Cancer Trial 12/9/2011  More...
Gilead Sciences, Inc. (GILD)'s Cobicistat Shows Efficacy in Phase 3 Study 12/7/2011  More...
Regeneron Pharmaceuticals, Inc. (REGN)-Bayer HealthCare (BAY) Drug Matches Lucentis at 2 Years in Fewer Doses 12/6/2011  More...
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE) Clot Drug Fails to Help Ill Patients 11/15/2011  More...
Genzyme Corporation (GENZ) MS Drug Significantly Reduces Relapse, Disability in Phase III Trial 11/15/2011  More...
Eli Lilly and Company (LLY) Experimental Drug Doubles Good Cholesterol in Race With Merck & Co., Inc. (MRK), Roche (RHHBY) 11/15/2011  More...
Roche (RHHBY)'s New MS Drug "Cuts Relapses by 80 Percent" in Phase 2 Trial 11/4/2011  More...
Shire plc Soars on Positive Phase 3 Prostate Cancer Data 11/4/2011  More...
Biogen Idec, Inc. (Massachusetts) (BIIB)'s Oral MS Drug Shines in Phase 3 Study 10/24/2011  More...
GlaxoSmithKline (GSK)'s Malaria Vaccine Works in Major Trial 10/21/2011  More...
Teva Pharmaceutical Industries Limited (TEVA) and Active Biotech AB (BTPC) Laquinimod Trial for MS Treatment Yields Positive Results 10/20/2011  More...
Halozyme Therapeutics, Inc. (HALO) Announces Positive Results from Roche (RHHBY)'s Subcutaneous Herceptin Phase 3 Trial 10/19/2011  More...
Merck & Co., Inc. (MRK)'s ISENTRESS(R) (raltegravir) in Combination Therapy Shows Benefits Over Efavirenz 10/13/2011  More...
VA Halts Roche (RHHBY)'s Avastin for Eye Disease; Rival Regeneron Pharmaceuticals, Inc. (REGN)'s Stock Surges 9/23/2011  More...
Gilead Sciences, Inc. (GILD) Bumps Up Filing Timeline for Quad Pill, HIV Med Outperforms Rival in Study 9/21/2011  More...
Nektar Therapeutics (CA) (NKTR) Release: Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the American Society of Clinical Oncology 2011 Breast Cancer Symposium 9/12/2011  More...
Pfizer Inc. (PFE)'s Arthritis Pill Tofacitinib Matches Abbott Laboratories (ABT)'s Humira in Final Studies 9/9/2011  More...
AstraZeneca PLC (AZN)'s Crestor Fails to Beat Pfizer Inc. (PFE)'s Lipitor 9/6/2011  More...
Amgen (AMGN), Cytokinetics, Inc. (CYTK) Heart Failure Class Shows Promise in Phase II 8/22/2011  More...
Endo Pharmaceuticals (ENDP) Terminates Pain Program After Failed Trial; Ends Pact With Grunenthal GmbH 8/19/2011  More...
Topline Results for GlaxoSmithKline (GSK)'s Second Phase III Parkinson's Drug Study 8/16/2011  More...
Gilead Sciences, Inc. (GILD)'s Quad JOV Drug Shows Positive Results in Phase III Trial 8/15/2011  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) and Abbott Laboratories (ABT) Report Top-Line Positive Results for Daclizumab HYP Trial in RRMS 8/10/2011  More...
GlaxoSmithKline (GSK)-Pfizer Inc. (PFE) AIDS Pill May Dislodge Bristol-Myers Squibb Company (BMY)'s, Study Suggests 7/28/2011  More...
Genentech (RHHBY) Drug Impresses in Phase III Trial; to Seek Approval by Year End 7/27/2011  More...
Amylin Pharmaceuticals, Inc. (AMLN), Alkermes (ALKS) Shares Jump on Success in Bydureon Study 7/27/2011  More...
Sanofi (France) (SASY.PA)/Regeneron Pharmaceuticals, Inc. (REGN)'s Sarilumab Shines for Rheumatoid Arthritis, Fails in Ankylosing Spondylitis in Phase 2b Trial 7/27/2011  More...
Nabi Biopharmaceuticals (NABI) Shares Plunge After Smoke-Cessation Drug Shown Ineffective in Study 7/19/2011  More...
Vertex Pharmaceuticals (MA) (VRTX) Slides as Cystic Fibrosis Drug Shows Promise but Also Raises Questions in Phase II Trial 6/30/2011  More...
Roche (RHHBY) Melanoma Drug Cuts Risk Of Death By 63 Percent; Bests Bristol-Myers Squibb Company (BMY) In Study 6/29/2011  More...
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE) Blood Thinner Tops Warfarin in Stroke Study, Wows Investors 6/29/2011  More...
Pfizer Inc. (PFE) Lung Cancer Pill May Double Survival 6/29/2011  More...
Exelixis, Inc. (EXEL) Drug Slows Prostate Cancer Spread In Trial But Also Reports Deaths in Study 6/8/2011  More...
Pfizer Inc. (PFE) Presents New Phase 3 Data Showing Axitinib Significantly Extended Progression-Free Survival Compared With Sorafenib In Patients With Previously-Treated Advanced Renal Cell Carcinoma 5/19/2011  More...
Pfizer Inc. (PFE) Lung Cancer Drug Shows Survival Benefit 5/18/2011  More...
Pearl Therapeutics' Phase IIb Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva(R) and Foradil(R) in Patients with COPD 5/18/2011  More...
Amgen (AMGN)'s XGEVA Phase 3 Trial Meets Primary Endpoint 5/18/2011  More...
New Study Reveals Risks with Roche (RHHBY)’s Avastin for Wet AMD Versus Novartis AG's Lucentis 5/5/2011  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Shares Soar on Multiple Sclerosis Drug Data 4/22/2011  More...
Amgen (AMGN) and UCB, Inc. (UCBJF.PK) Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO) 4/21/2011  More...
Novartis AG, Sosei Co., Ltd. COPD Drug Phase III Trial Meets Primary Endpoint 4/19/2011  More...
Amarin Corporation PLC (AMRN)'s Late-stage AMR101 Study Meets Key Goals In Mixed Dyslipidemia Patients 4/18/2011  More...
Phase III Clinical Trial of Gilead Sciences, Inc. (GILD)’s Investigational Elvitegravir Meets 48-Week Primary Objective 3/23/2011  More...
Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (France) (SAN.PA) Cancer Drug Misses Phase III Primary Endpoint but Meets Secondary Targets 3/14/2011  More...
Amylin Pharmaceuticals, Inc. (AMLN) Exenatide Once Monthly Showed Positive Results in Phase 2 Study 3/10/2011  More...
Eli Lilly and Company (LLY), Amylin Pharmaceuticals, Inc. (AMLN) and Alkermes plc (ALKS)' Bydureon Fails Against {4}'s Victoza in Head to Head Study 3/3/2011  More...
Regeneron Pharmaceuticals, Inc. (REGN)'s ARCALYST(R) (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 2/28/2011  More...
Exelixis, Inc. (EXEL) Cabozantinib (XL184) Phase 2 Data Demonstrate Encouraging Clinical Activity in Patients with Castration-Resistant Prostate Cancer 2/18/2011  More...
Renovo Group Plc (RNVO.L) Falls As Juvista Fails In Clinical Trial 2/11/2011  More...
Idenix Pharmaceuticals, Inc. (IDIX) Cancels Hepatitis C Drug On Toxicity Worries; Shares Fall 2/10/2011  More...
Genentech (RHHBY): Third Phase III Study of Avastin-Based Regimen Met Primary Endpoint in Ovarian Cancer 2/8/2011  More...
Optimer Pharmaceuticals, Inc. (OPTR) Antibiotic Cuts Recurrence of Deadly Bacteria 2/3/2011  More...
Chelsea Therapeutics, Inc. (CHTP) Announces Interim Results and Plans to Modify Study 306 to Focus on Reduction in Falls Associated With Neurogenic Orthostatic Hypotension 2/2/2011  More...
Merck & Co., Inc. (MRK) Says Clot Preventer has Bleeding Risk 1/20/2011  More...
Plexxikon Inc., Roche Holding AG (RHHBF.PK) Report Overall Survival Benefit for Melanoma Patients in PLX4032 Phase 3 Trial 1/19/2011  More...
Targacept, Inc. (TRGT) Announces Positive Top-Line Results from Phase 2 Trial of TC-5619 in Cognitive Dysfunction in Schizophrenia 1/19/2011  More...
Ariad Pharmaceuticals, Inc. (ARIA)'s Drug Ridaforolimus Meets Main Goal In Phase III Trial Of Bone Sarcomas 1/18/2011  More...
Lexicon Pharmaceuticals, Inc. (LXRX) Shares Jump on Positive Diabetes Study Results 1/7/2011  More...
Teva Pharmaceutical Industries Limited (TEVA)/Active Biotech AB's MS Pill Shines in Phase III Study 12/9/2010  More...
Onyx Pharmaceuticals, Inc. (ONXX) Drug Carfilzomib Reduces Cancer in a Third of Patients With Deadly Blood Cancer in Phase 2 Study; Raising Stakes in Rivalry with Millennium: The Takeda Oncology Company 12/8/2010  More...
Seattle Genetics, Inc. (SGEN) and Millennium: The Takeda Oncology Company's Experimental Drug, SGN-35 Shrinks Hodgkin's Tumors, Study Shows 12/7/2010  More...
Pfizer Inc. (PFE)'s Investigational Compound Bosutinib Fails to Meet Primary Endpoint in Phase 3 Study For Chronic Myeloid Leukemia 12/7/2010  More...
Amarin Corporation PLC (AMRN) Omega-3 Drug, AMR101, Lowers Blood-Fat Levels in Clinical Trial; Stock Rises; Drug Will Be Submitted for FDA Approval Earlier Than Expected 11/30/2010  More...
Next Big Thing? Big Cholesterol Drop with New Drug, Anacetrapib from Merck & Co., Inc. (MRK) in Phase III Study 11/17/2010  More...





 

//-->